Skip to main content
. 2021 Apr 7;16:2703–2714. doi: 10.2147/IJN.S298159

Figure 2.

Figure 2

Schematic of the macrophage-derived microvesicle-coated tacrolimus-loaded nanoparticles (MNPs). MNPs could target sites of rheumatoid arthritis through bound to P-selectin or ICAM-1 on endothelial cells.

Notes: Reprinted with permission from Li R, He Y, Zhu Y, et al. Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano letters. 2019; 19(1):124–134. Copyright (2019) American Chemical Society.23